FDA Inspection 1071273 — Everest Life Sciences LLC
The FDA completed an inspection of Everest Life Sciences LLC on Oct 23, 2018 in Plainsboro, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 23, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Plainsboro, NJ (United States)
Additional details
Sponsor, Contract Research Organization